Glaxo SmithKline
Last Updated:
- 30.44 EGP
- 0.36
- 1.20%
جلاكسو سميثكلاين
جلاكسو سميثكلاين
Symbol :
BIOC
ISIN :
EGS38171C012
52-Week Range :
26.26
-
47.50
Turnover Ratio :
0.17
Market :
Egyptian Exchange
Sector :
Health Care & Pharmaceuticals
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Glaxo SmithKline Announcements
Top News
- A 30-April GSK Egypt obtains shareholders’ nod for 2023 cash dividends
- B 04-March GSK Egypt’s consolidated profits plunge to EGP 60m in 2023; dividends approved
- C 19-November GSK Egypt records plunge in 9M-23 profits; sales hit EGP 1.57bn
- D 16-August GSK Egypt’s net profits shrink in H1-23 results
- E 01-June GSK Egypt generates lower consolidated profits in Q1-23
- F 04-May GSK Egypt’s shareholders approve 2022 cash dividends
- G 03-April GSK Egypt records 376% leap in 2022 consolidated profits; dividends announced
- H 30-November GSK Egypt sees surge in 9M-22 consolidated profits
- I 17-November GSK Egypt posts higher standalone profits at EGP 930m in 9M-22
- J 31-August GSK Egypt’s profits climb to EGP 872m in H1-22
- K 14-June GSK Egypt's consolidated profits skyrocket in Q1-22
- L 01-June GSK Egypt's standalone profits hike in Q1-22
